Market Overview

OptimizeRx: Q3 Earnings Insights


Shares of OptimizeRx (NASDAQ:OPRX) were flat in after-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share rose 240.00% over the past year to $0.07, which beat the estimate of $0.04.

Revenue of $10,519,000 rose by 110.25% year over year, which beat the estimate of $9,770,000.

Looking Ahead

Earnings guidance hasn't been issued by the company for now.

Revenue guidance hasn't been issued by the company for now.

Details Of The Call

Date: Nov 09, 2020

Time: 04:30 PM

ET Webcast URL:

Price Action

Company's 52-week high was at $22.55

Company's 52-week low was at $6.50

Price action over last quarter: Up 23.90%

Company Overview

OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution support patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.


Related Articles (OPRX)

View Comments and Join the Discussion!

Posted-In: Earnings